Sequoia Financial Advisors, LLC Amgen Inc Transaction History

Sequoia Financial Advisors, LLC

$8.93 Billion
Q3 2024

A detailed history of Sequoia Financial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sequoia Financial Advisors, LLC holds 134,582 shares of AMGN stock, worth $35.4 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

134,582

Previous 122,903 9.5%

Holding current value

$35.4 Million

Previous $38.4 Million 12.92%

% of portfolio

0.49%

Previous 0.48%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$309.38 - $337.38 $3.61 Million - $3.94 Million	11,679 Added 9.5%	134,582 $43.4 Million
Q2 2024 Jul 15, 2024	BUY	$262.75 - $319.31 $1.1 Million - $1.34 Million	4,196 Added 3.53%	122,903 $38.4 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $12.8 Million - $15.4 Million	47,466 Added 66.63%	118,707 $33.8 Million
Q4 2023 Jan 25, 2024	BUY	$255.7 - $288.46 $14.6 Million - $16.4 Million	56,951 Added 398.54%	71,241 $20.5 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $38,482 - $47,776	-176 Reduced 1.22%	14,290 $3.84 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $186,629 - $220,685	871 Added 6.41%	14,466 $3.21 Million
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $77,220 - $94,118	342 Added 2.58%	13,595 $3.29 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $20,612 - $26,190	-90 Reduced 0.67%	13,253 $3.48 Million
Q4 2022 Jan 17, 2023	BUY	$229.03 - $291.01 $1.76 Million - $2.23 Million	7,674 Added 135.37%	13,343 $0
Q3 2022 Oct 26, 2022	SELL	$224.46 - $253.15 $862,375 - $972,602	-3,842 Reduced 40.4%	5,669 $1.28 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $505,024 - $562,003	-2,189 Reduced 18.71%	9,511 $2.31 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $121,914 - $134,868	556 Added 4.99%	11,700 $2.83 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $883,822 - $1.01 Million	4,444 Added 66.33%	11,144 $2.51 Million
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $880,708 - $1.03 Million	-4,149 Reduced 38.24%	6,700 $1.43 Million
Q2 2021 Jul 27, 2021	SELL	$233.58 - $259.14 $29,431 - $32,651	-126 Reduced 1.15%	10,849 $2.64 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $215,252 - $250,842	970 Added 9.7%	10,975 $2.73 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $56,907 - $67,767	263 Added 2.7%	10,005 $2.3 Million
Q3 2020 Oct 23, 2020	BUY	$234.65 - $260.95 $14,548 - $16,178	62 Added 0.64%	9,742 $2.48 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $76,552 - $93,940	387 Added 4.16%	9,680 $2.28 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $257,322 - $341,280	1,412 Added 17.92%	9,293 $1.88 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $55,060 - $70,771	291 Added 3.83%	7,881 $1.9 Million
Q3 2019 Oct 22, 2019	SELL	$174.11 - $208.62 $23,504 - $28,163	-135 Reduced 1.75%	7,590 $1.47 Million
Q2 2019 Jul 31, 2019	BUY	$166.7 - $195.41 $3,000 - $3,517	18 Added 0.23%	7,725 $1.42 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $241,823 - $272,587	1,337 Added 20.99%	7,707 $1.46 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $120,420 - $140,568	675 Added 11.85%	6,370 $1.24 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $49,843 - $56,191	-269 Reduced 4.51%	5,695 $1.18 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $213,042 - $239,292	1,283 Added 27.41%	5,964 $1.1 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $17,620 - $20,592	-104 Reduced 2.17%	4,681 $798,000
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $70,723 - $79,019	419 Added 9.6%	4,785 $832,000
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $40,651 - $46,413	-243 Reduced 5.27%	4,366 $814,000
Q2 2017 Aug 09, 2017	BUY	N/A	4,609	4,609 $794,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.

Account

Sequoia Financial Advisors, LLC Amgen Inc Transaction History